BDRX (Biodexa Pharmaceuticals plc American Depositary Shs) Stock Analysis - Financials

Biodexa Pharmaceuticals plc American Depositary Shs (BDRX) is a publicly traded Healthcare sector company. As of May 21, 2026, BDRX trades at $3.11 with a market cap of $2.04M and a P/E ratio of 0.00. BDRX moved +0.00% today. Year to date, BDRX is -75.22%; over the trailing twelve months it is -95.29%. Its 52-week range spans $2.86 to $544.50. Rallies surfaces BDRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are BDRX's key financials?

BDRX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. BDRX recently traded at $3.11. Market cap is $2.04M. P/E ratio is 0.00. Revenue is $0.

BDRX Key Metrics

Key financial metrics for BDRX
MetricValue
Price$3.11
Market Cap$2.04M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$544.50
52-Week Low$2.86
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest BDRX News

BDRX Analyst Consensus

BDRX analyst coverage data. Average price target: $0.00.

Common questions about BDRX

What are BDRX's key financials?
BDRX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. BDRX recently traded at $3.11. Market cap is $2.04M. P/E ratio is 0.00. Revenue is $0.
Is BDRX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BDRX. It does not provide personalized investment advice.
BDRX

BDRX